Cefixime in the treatment of enteric fever in children.

Author: FaridZ, GirgisN I, KilpatrickM E, PodgoreJ K, SultanY

Paper Details 
Original Abstract of the Article :
Cefixime in a dose 20 mg/kg/day, orally, divided into two doses 12 h apart for a minimum of 12 days, was administered to 50 children with proven S. typhi septicaemia. Forty four of the patients were infected with strains of S. typhi resistant to multiple antibiotics including chloramphenicol, ampici...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/8223140

データ提供:米国国立医学図書館(NLM)

Cefixime: A New Hope for Treating Typhoid Fever

Imagine a traveler in the desert, weakened by a fever. This is similar to the plight of children suffering from typhoid fever. This study investigated the effectiveness of cefixime, an oral antibiotic, in treating children with typhoid fever, specifically those infected with multi-drug resistant strains.

Cefixime’s Promise in the Fight Against Typhoid

Cefixime was administered to 50 children with confirmed typhoid fever, most of whom were infected with strains resistant to common antibiotics. The study found that cefixime was highly effective, with rapid improvement in fever and overall health. Importantly, only two children relapsed during the follow-up period. This suggests that cefixime could be a valuable alternative for treating typhoid fever, especially in cases where standard antibiotics have failed.

Cefixime: A Boon for Typhoid Treatment

Cefixime's effectiveness in treating typhoid fever, particularly multi-drug resistant strains, is significant. Its oral formulation also makes it convenient for patients who are able to tolerate oral feeding. This research is like an oasis in the desert, offering a promising treatment option for children suffering from typhoid fever.

Dr.Camel's Conclusion

Cefixime stands as a beacon of hope in the desert of typhoid fever. Its effectiveness and convenience make it a potential game-changer for treating this challenging infection. This study reminds us that the fight against infectious diseases is an ongoing journey, and new solutions are constantly emerging.

Date :
  1. Date Completed 1993-12-01
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

8223140

DOI: Digital Object Identifier

8223140

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.